Company Search:
Advanced Search
Sponsored Links
Incyte Corp. Company Snapshot
Incyte Corp. operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Incyte Corp. with three other companies in this sector in the United States: Albany Molecular Research Incorporated (2016 sales of $570.45 million of which 61% was API), Bioverativ Inc ($887.40 million ), and Syneos Health Inc ($1.61 billion of which 63% was Clinical Development Services).

Sales Analysis. During the year ended December of 2016, sales at Incyte Corp. were $1.11 billion. This is an increase of 46.7% versus 2015, when the company's sales were $753.75 million. This was the fifth consecutive year of sales increases at Incyte Corp. (and since 2011, sales have increased a total of 1,071%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Incyte Corp.
  Stock Performance Chart for Incyte Corp.
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 94.07
(Figures in U.S. Dollars)
1 Week -5.8%   13 Weeks -2.4%  
4 Weeks -17.7%   52 Weeks -20.1%  
Incyte Corp. Key Data:
  Ticker: INCY Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Commercial Physical Research
  2016 Sales 1,105,719,000
(Year Ending Jan 2017).
Employees: 980
  Currency: U.S. Dollars Market Cap: 19,852,279,658
  Fiscal Yr Ends: December Shares Outstanding: 211,037,309
  Share Type: Common Closely Held Shares: 1,043,775
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.